150
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Blood Pressure Control and Adherence to Drug Treatment in Patients with Hypertension Treated at a Specialized Outpatient Clinic: A Cross-Sectional Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2749-2761 | Published online: 10 Dec 2021

References

  • Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–237. doi:10.1038/s41581-019-0244-2
  • GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923–1994. doi:10.1016/S0140-6736(18)32225-6
  • GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. doi:10.1016/S0140-6736(18)32203-7
  • Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–450. doi:10.1161/CIRCULATIONAHA.115.018912
  • Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One. 2012;7:e48255. doi:10.1371/journal.pone.0048255
  • Picon RV, Fuchs FD, Moreira LB, Fuchs SC. Prevalence of hypertension among elderly persons in urban Brazil: a systematic review with meta-analysis. Am J Hypertens. 2013;26:541–548. doi:10.1093/ajh/hps076
  • Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–967. doi:10.1016/S0140-6736(15)01225-8
  • NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639–651. doi:10.1016/S0140-6736(19)31145-6
  • Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959–968. doi:10.1001/jama.2013.184182
  • Lopes RD, Barroso WKS, Brandao AA, et al. The first Brazilian registry of hypertension. Am Heart J. 2018;205:154–157. doi:10.1016/j.ahj.2018.08.012
  • Malachias MVB, Souza WKSB, Plavnik FL, et al. 7th Brazilian guideline of arterial hypertension. Arq Bras Cardiol. 2016;107:1–83. doi:10.5935/abc.20160140
  • Redon J, Mourad JJ, Schmieder RE, Volpe M, Weiss TW. Why in 2016 are patients with hypertension not 100% controlled? A call to action. J Hypertens. 2016;34:1480–1488. doi:10.1097/HJH.0000000000000988
  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041. doi:10.1097/HJH.0000000000001940
  • Whelton PK, Carey RM. The 2017 clinical practice guideline for high blood pressure. JAMA. 2017;318:2073–2074. doi:10.1001/jama.2017.18209
  • Barroso WKS, Rodrigues CS, Bortolotto LA, et al. Brazilian guideline of hypertension - 2020. Arq Bras Cardiol. 2020. doi:10.36660/abc.20201238
  • Sabaté E. World Health Organization report: adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003. Available from: http://www.who.int/chronic_conditions/adherencereport/en/. Accessed November 17, 2021.
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691‐705. doi:10.1111/j.1365-2125.2012.04167.x.
  • Burnier M, Egan MB. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circ Res. 2019;124:1124–1140. doi:10.1161/CIRCRESAHA.118.313220
  • Pinho NA, Pierin AMG. Hypertension control in Brazilian publications. Arq Bras Cardiol. 2013;101:e65–e73. doi:10.5935/abc.20130173
  • O’Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP 5332, and Nissei DS-175. Blood Press Monit. 1996;1:55–61.
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74. doi:10.1097/00005650-198601000-00007
  • Oliveira-Filho AD, Morisky DE, Neves SJ, Costa FA, de Lyra DP. The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults. Res Social Adm Pharm. 2014;10:554–561. doi:10.1016/j.sapharm.2013.10.006
  • ABEP. Brazil economic classification criterion. Brazilian Association of Research Companies; 2008.
  • Lima CT, Freire AC, Silva AP, Teixeira RM, Farrell M, Prince M. Concurrent and construct validity of the audit in an urban Brazilian sample. Alcohol Alcohol. 2005;40:584–589. doi:10.1093/alcalc/agh202
  • Matsudo S, Araujo T, Matsudo V, et al. Questionário Internacional de Atividade Física (IPAQ): estudo de validade e reprodutibilidade no Brasil. Ativ Fis e Saúde. 2001;6:5–18. doi:10.12820/rbafs.v.6n2p5-18
  • Mari JJ, Williams P. A validity study of a psychiatric screening questionnaire (SRQ-20) in primary care in the city of Sao Paulo. Br J Psychiatry. 1986;148:23–26. doi:10.1192/bjp.148.1.23
  • Schiffrin EL, Campbell NR, Feldman RD, et al. Hypertension in Canada: past, present, and future. Ann Glob Health. 2016;82:288–299. doi:10.1016/j.aogh.2016.02.006
  • Muntner P, Hardy S, Fine L, et al. Trends in blood pressure control among us adults with hypertension, 1999–2000 to 2017–2018. JAMA. 2020;324:1190–1200. doi:10.1001/JAMA.2020.14545
  • Nascimento BR, Brant LCC, Yadgir S, et al. Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the “Global Burden of Disease 2017” (GBD 2017) study. Popul Health Metr. 2020;18:17. doi:10.1186/s12963-020-00218-z
  • Beaney T, Schutte AE, Tomaszewski M, et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6:e736–e743.
  • Firmo JOA, Peixoto SV, Loyola Filho AI, et al. Health behaviors and hypertension control: the results of ELSI-BRASIL. Cad Saúde Pública. 2019;35:e00091018. doi:10.1590/0102-311X00091018
  • Chor D, Ribeiro AL, Carvalho MS, et al. Prevalence, awareness, treatment and influence of socioeconomic variables on control of high blood pressure: results of the ELSA-Brasil Study. PLoS One. 2015;10:e0127382. doi:10.1371/journal.pone.0127382
  • Colósimo FC, Silva SSBE, Toma GA, Pierin AMG. Nursing actions increases the control of hypertensive patients and reduces white-coat effect. Rev Esc Enferm USP. 2012;46:10–15. doi:10.1590/S0080-62342012000700002
  • Tucker KL, Sheppard JP, Stevens R, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14:e1002389. doi:10.1371/journal.pmed.1002389
  • Nielsen JO, Shrestha AD, Neupane D, Kallestrup P. Nonadherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects. J Hum Hypertens. 2017;31:14–21. doi:10.1038/jhh.2016.31
  • Wong CW, Kwok CS, Narain A, et al. Marital status and risk of cardiovascular diseases: a systematic review and meta-analysis. Heart. 2018;104:1937–1948. doi:10.1136/heartjnl-2018-313005
  • Pietrzykowski Ł, Michalski P, Kosobucka A, et al. Medication adherence and its determinants in patients after myocardial infarction. Sci Rep. 2020;10:12028. doi:10.1038/s41598-020-68915-1
  • Li T, Song X, Wu J, et al. Awareness of hypertension and related factors in northeastern China: a cross-sectional study. J Hum Hypertens. 2020;34:43–50. doi:10.1038/s41371-019-0263-2
  • Hosseini Z, Veenstra G, Khan NA, Conklin AI. Social connections and hypertension in women and men: a population-based cross-sectional study of the Canadian Longitudinal Study on Aging. J Hypertens. 2021;39:651–660. doi:10.1097/HJH.0000000000002688
  • Manfredini R, De Giorgi A, Tiseo R, et al. Marital status, cardiovascular diseases, and cardiovascular risk factors: a review of the evidence. J Womens Health. 2017;26:624–632. doi:10.1089/jwh.2016.6103
  • Jayedi A, Rashidy-Pour A, Khorshidi M, Shab-Bidar S. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose-response meta-analysis of more than 2.3 million participants. Obes Rev. 2018;19:654–667. doi:10.1111/obr.12656
  • Roldan PC, Ho GY, Ho PM. Updates to adherence to hypertension medications. Curr Hypertens Rep. 2018;20:1–7. doi:10.1007/s11906-018-0830-x
  • Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: a population-based retrospective cohort study. PLoS Med. 2018;15:e1002584. doi:10.1371/journal.pmed.1002584
  • Poulter NR, Borghi C, Parati G, et al. Medication adherence in hypertension. J Hypertens. 2020;38:579–587. doi:10.1097/HJH.0000000000002294
  • Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current Situation of Medication Adherence in Hypertension. Front Pharmacol. 2017;8:100. doi:10.3389/fphar.2017.00100
  • Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine. 2017;96:e5641. doi:10.1097/MD.0000000000005641
  • Venkataraman R, Rashid M, Shashikantha B, et al. Prescribing pattern of antihypertensive medication and adherence to Joint National Commission-8 guidelines in a rural tertiary care Indian teaching hospital. J Basic Clin Physiol Pharmacol. 2019;31. doi:10.1515/jbcpp-2019-0133